Publication | Open Access
Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy
216
Citations
24
References
2001
Year
The effects of fidarestat-treatment on nerve conduction and the subjective symptoms of diabetic neuropathy provide evidence that this treatment alters the progression of diabetic neuropathy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1